The Role of ApoE Polymorphism in the Relationship Between Serum Steroid Hormone Levels and Cognition in Older Chinese Adults: A Cross-Sectional Study

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2018 Mar 22

PMID 29559956

Authors

Xiaochen Huang

Shengqi Dong

Jie Zhen

Huiqiang Zhang

Tong Lin

Yuhong Zeng

Nicholas Van Halm-Lutterodt

Linhong Yuan

Affiliations

Soon will be listed here.

Abstract

Background: Epidemiology studies have indicated an association of apolipoprotein E (ApoE) genetic polymorphism and circulating steroid hormone levels with the risk of Alzheimer's disease. The established physiologic relationship between apolipoproteins and steroid hormone indicate an important role of ApoE polymorphism in impacting the relationship between serum steroid hormones and cognition in the elderly.

Study Design: A total of 500 Chinese adults aged between 50 and 75 participated in this community-based cross-sectional study. Blood samples were collected in the morning for ApoE genotyping and serum parameter assessment. Cognitive performance of participants was evaluated by Montreal Cognitive Assessment test.

Results: Age, gender, educational level, smoking, and physical activity levels are factors associated with cognitive performance in this older Chinese adults. Compared to the control subjects, MCI subjects demonstrated higher serum total cholesterol, HDL-C, and estradiol status ( < 0.05). ApoE genotype difference of serum lipid profile was observed with a relatively higher mean serum triglyceride levels in ApoE2 and ApoE4 carriers ( < 0.05), and lower mean serum HDL-C level in ApoE4 carriers ( < 0.05). Memory and delayed recall ability was serum estradiol level related; and subjects with higher circulating estradiol concentration exhibited lower memory and delayed recall ability ( < 0.05). The association of serum estradiol and cortisol concentration with cognitive performance was ApoE genotypes dependent. Poor cognitive performance was observed in ApoE2 and ApoE4 carriers with higher serum estradiol level ( < 0.05). Moreover, ApoE2 and ApoE4 carriers with higher serum cortisol status demonstrated decreased language ability ( < 0.05). Multiple logistic regression analysis indicates that subjects with higher serum estradiol status may have an increased risk for MCI [OR = 2.004, 95% confidence interval (CI): 1.135, 3.540; = 0.017]. ApoE2 carriers with higher serum steroid levels may be potentially predisposed to an increased risk of MCI (OR = 3.353; 95% CI: 1.135, 9.907; = 0.029).

Conclusion: Cognitive outcomes in older Chinese adults are associated with serum steroid hormone status. Higher serum steroid levels in ApoE2 carriers might pose an increased risk of MCI in the elderly.

References

Lupien S, De Leon M, De Santi S, Convit A, Tarshish C, Nair N . Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci. 1999; 1(1):69-73. DOI: 10.1038/271. View

Davignon J, Cohn J, Mabile L, Bernier L . Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta. 1999; 286(1-2):115-43. DOI: 10.1016/s0009-8981(99)00097-2. View

Bonarek M, Barberger-Gateau P, Letenneur L, Deschamps V, Iron A, Dubroca B . Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study. Neuroepidemiology. 2000; 19(3):141-8. DOI: 10.1159/000026249. View

Roozendaal B . 1999 Curt P. Richter award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology. 2000; 25(3):213-38. DOI: 10.1016/s0306-4530(99)00058-x. View

Merched A, Xia Y, Visvikis S, Serot J, Siest G . Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging. 2000; 21(1):27-30. DOI: 10.1016/s0197-4580(99)00103-7. View

Jack Jr C, Petersen R, Xu Y, OBrien P, Smith G, Ivnik R . Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000; 55(4):484-89. PMC: 2724764. DOI: 10.1212/wnl.55.4.484. View

Siest G, Bertrand P, Qin B, Herbeth B, Serot J, Masana L . Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group. Clin Chem Lab Med. 2000; 38(8):721-30. DOI: 10.1515/CCLM.2000.102. View

Peskind E, Wilkinson C, Petrie E, Schellenberg G, Raskind M . Increased CSF cortisol in AD is a function of APOE genotype. Neurology. 2001; 56(8):1094-8. DOI: 10.1212/wnl.56.8.1094. View

Fujishima M, Kiyohara Y . Incidence and risk factors of dementia in a defined elderly Japanese population: the Hisayama study. Ann N Y Acad Sci. 2002; 977:1-8. DOI: 10.1111/j.1749-6632.2002.tb04793.x. View

10.

Tan Z, Seshadri S, Beiser A, Wilson P, Kiel D, Tocco M . Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003; 163(9):1053-7. DOI: 10.1001/archinte.163.9.1053. View

11.

Diamond D, Bennett M, Fleshner M, Rose G . Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 1992; 2(4):421-30. DOI: 10.1002/hipo.450020409. View

12.

Panza F, DIntrono A, Colacicco A, Basile A, Capurso C, Kehoe P . Vascular risk and genetics of sporadic late-onset Alzheimer's disease. J Neural Transm (Vienna). 2004; 111(1):69-89. DOI: 10.1007/s00702-003-0071-1. View

13.

Nathan B, Barsukova A, Shen F, McAsey M, Struble R . Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology. 2004; 145(7):3065-73. DOI: 10.1210/en.2003-1707. View

14.

Qiu C, Kivipelto M, Aguero-Torres H, Winblad B, Fratiglioni L . Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry. 2004; 75(6):828-33. PMC: 1739059. DOI: 10.1136/jnnp.2003.021493. View

15.

Reitz C, Tang M, Luchsinger J, Mayeux R . Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. 2004; 61(5):705-14. PMC: 2696387. DOI: 10.1001/archneur.61.5.705. View

16.

Bowen R, Gregory C . Sex hormones and ApoE4: beyond steroids. J Alzheimers Dis. 2004; 6(3):229-30. DOI: 10.3233/jad-2004-6303. View

17.

Solfrizzi V, Panza F, Colacicco A, DIntrono A, Capurso C, Torres F . Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology. 2004; 63(10):1882-91. DOI: 10.1212/01.wnl.0000144281.38555.e3. View

18.

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

19.

Kaufman J, Vermeulen A . The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005; 26(6):833-76. DOI: 10.1210/er.2004-0013. View

20.

Mielke M, Zandi P, Sjogren M, Gustafson D, Ostling S, Steen B . High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005; 64(10):1689-95. DOI: 10.1212/01.WNL.0000161870.78572.A5. View